BioXcel

Branford, United States Founded: 2006 • Age: 20 yrs
Cloud-based big data analytics solutions are provided for healthcare industries.

About BioXcel

BioXcel is a company based in Branford (United States) founded in 2006 by Bhavish Aggarwal. The company has 42 employees. BioXcel operates in a competitive market with competitors including Formation Bio, Owkin, BigHat, Benchsci and Predictive Oncology, among others.

  • Headquarter Branford, United States
  • Employees 42
  • Founders Bhavish Aggarwal
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website bioxcel.com
  • Social LinkedIn X
  • Legal Name E Z Bioxcel Solutions Private Limited
  • Date of Incorporation 22 Nov, 2005
  • Jurisdiction New Delhi, Delhi, India
Key Metrics
  • Annual Revenue
    ₹11.59 Cr

    FY 2024 · -27% YoY

  • Net Profit
    ₹1.01 Cr

    FY 2024 · 9% margin

  • EBITDA
    ₹1.48 Cr

    FY 2024 · 13% margin

  • Employee Count
    42

Board of directors of E Z Bioxcel Solutions Private Limited (BioXcel)

E Z Bioxcel Solutions Private Limited is the primary company behind BioXcel. The board of E Z Bioxcel Solutions Private Limited currently have 3 directors; the longest-serving is Ankush Sethi, appointed in 2005.

DirectorDesignationAppointedTenureEntity
Ankush Sethi
DIN 01315523
Managing Director22 Nov 200520 yrs 10 moE Z Bioxcel Solutions Private Limited
Krishnan Nandabalan
DIN 01412880
Director18 Jan 200620 yrs 8 moE Z Bioxcel Solutions Private Limited
Vimal Deep Mehta
DIN 02293364
Director01 Mar 200917 yrs 7 moE Z Bioxcel Solutions Private Limited

People of BioXcel

11 people are tracked at BioXcel (6 in leadership, 2 in board & advisors, 3 in team); the tracked headcount is 42.

NameRoleGroup
Bhavish Aggarwal
Co-Founder & CEOLeadership
CEO & ChairmanLeadership
David Dean
CFOLeadership
Frank D. Yocca
Senior Vice President CNS Research and DevelopmentLeadership
Pooja Chatley
Medical DirectorLeadership
Himani Sharma
VP, Corporate Strategy & Innovation, BioXcel IndiaLeadership
Demetrios Kydonieus
DirectorBoard & advisors
Peter Mueller
Chairman, Scientific Advisory BoardBoard & advisors
renu khatri
Manager, Consulting & InnovationTeam
Manish Gupta, Ph.D.
Senior ManagerTeam
Abhishek Sharma
Database ManagerTeam
Premium access

Complete people profiles for BioXcel

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of BioXcel

Figures of E Z Bioxcel Solutions Private Limited, the primary company behind BioXcel, for FY 2024. Revenue was ₹11.59 Cr (-27% year on year). Net profit was ₹1.01 Cr (9% margin). EBITDA was ₹1.48 Cr (13% margin). Revenue has grown at a compounded annual rate of -1% over three years and +3% over five years.

  • ₹11.59 CrRevenue · FY 2024 · -27% YoY
  • ₹1.01 CrNet profit · 9% margin
  • ₹1.48 CrEBITDA · 13% margin
  • ₹2 LakhPaid-up capital
  • 42Employees (provident fund records)
  • -1%Revenue CAGR, 3 years
  • +3%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of E Z Bioxcel Solutions Private Limited are on its company page.

Premium access

Detailed financial statements for BioXcel

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Competitors of BioXcel

BioXcel operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Formation Bio, Owkin, BigHat, Benchsci and Predictive Oncology, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
formation.bio2016New York, United States$608M–
AI-powered drug discovery platform for various diseases
owkin.com2016Paris, France$321.1M47
An agentic AI platform is developed for biomedical research insights.
bighatbio.com2019San Carlos, United States$148.41M–
Antibody therapies are developed through machine learning and synthetic biology.
benchsci.com2015Toronto, Canada$157.73M–
AI platform used for extracting antibody data from scientific papers.
predictive-oncology.com2002Eagan, United States$43M31
AI-based platform for cancer diagnostics and precision medicine is utilized.
iambic.ai2019San Diego, United States$206.23M50
AI-driven drug discovery platform for the treatment of cancer
absci.com2011Vancouver, United States$227.56M256
AI-based technology is used for recombinant protein production in therapeutics.
xtalpi.com2014Cambridge, United States$783.5M33
AI-driven crystal structure prediction for pharmaceutical development is offered.
verisimlife.com2017San Francisco, United States$21.4M13
AI-based biosimulation models are used for drug development predictions.
Premium access

Detailed competitors of BioXcel

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of BioXcel

  • Global rank
    #8,974,920

    among all websites

  • Category rank
    #7,553

    Health · Biotechnology and Pharmaceuticals

Latest news on Bioxcel

Premium access

Complete news archive for BioXcel

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to BioXcel

10 companies that operate in the same segment as BioXcel (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M––
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B––
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.3 BUSD 301.49 M1,480
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Biological reagents and antibodies are developed for life science research.
1998Cambridge, Cambridgeshire, United KingdomUSD 78.8 M––
Electron microscopy services and microanalysis instruments are provided.
1956Waltham, Massachusetts, United States–USD 44.56 B125,000
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
A platform for sharing and accessing academic research papers is provided.
2008San Francisco, California, United StatesUSD 58.4 M––
Developer of molecular diagnostic testing solutions
1996Sunnyvale, California, United StatesUSD 19.1 MUSD 54.88 M208
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about BioXcel

BioXcel was founded in 2006.

BioXcel is headquartered in Branford, United States. It is registered at Branford, Connecticut, United States.

Bhavish Aggarwal is the current CEO of BioXcel. They have also founded this company.

BioXcel has 42 employees.

The primary company behind BioXcel, E Z Bioxcel Solutions Private Limited, reported revenue of ₹11.59 Cr for FY 2024, down 27% year on year.

BioXcel was founded in 2006 in Branford, United States, and operates in the healthcare sector. Cloud-based big data analytics solutions are offered, including a proprietary machine learning platform developed to identify new therapeutic uses for approved drugs. The lead product, BXCL501, is targeted at acute agitation treatment. Platform-enabled services and partnerships are provided, alongside a design studio that delivers insights with interactive intelligence.

BioXcel's top competitors include Owkin, Formation Bio and XtalPi.

BioXcel operates through E Z Bioxcel Solutions Private Limited.

The legal entities of BioXcel currently have 3 directors, including Ankush Sethi, Krishnan Nandabalan, Vimal Deep Mehta.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available